Administration of 666–15, a CREB specific inhibitor but unable to permeate the blood-brain barrier (Yang C. et al., 2021), significantly attenuates mechanical allodynia and thermal hyperalgesia, and reverses anxiety and depression-like behaviors in SNI rats. The gene discussed is CREB1; the disease is depressive disorder.